Covance Inc (CVD)
Financials 
Technical Analysis 0
PAST TOP PICK
TOP PICK
Largest company in the area of contract research for pharmaceuticals. They do drug trials and research for the large pharmaceutical and biotech companies. Had consistently traded at 25X-30X earnings but are now at 11X earnings. Great growth prospects ahead. Think they can grow at 15%-20% a year starting in 2010.
Don LatoOwned
biotechnologypharmaceutical
TOP PICK
Given with what's going on with Vioxx and Cellebrex, this company is very important as the FDA will be asking for lengthier testing on these areas. Looks on this as a fabulous growth story.
Elizabeth DaterOwned
biotechnologypharmaceutical
TOP PICK
TOP PICK
To a lot of testing and research for larger biotech companies. In a sweet spot.
Ed BrownOwned
biotechnologypharmaceutical
Showing 1 to 5 of 5 entries
- «
- ‹
- 1
- ›
- »
Popular Articles
Most Recent Experts
Covance Inc (CVD) Frequently Asked Questions
What is Covance Inc stock symbol?
Covance Inc is a OTC stock, trading under the symbol CVD (previously CVD-N on Stockchase) on the undefined (undefined). It is usually referred to as or CVD
Is Covance Inc a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on CVD (previously CVD-N on Stockchase) on Stockchase. Read the latest expert commentary for Covance Inc.
Is Covance Inc a good investment or a top pick?
Covance Inc was recommended as a Top Pick by Ed Brown on 2004-05-07. Read the latest stock experts ratings for Covance Inc.
Why is Covance Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Covance Inc.
Is Covance Inc worth watching?
Covance Inc is covered by Stockchase experts and is worth watching.